A recent study indicates that, in ESCC, high levels of riboflavin intake via SLC52A3 overexpression promotes tumorigenesis by sustaining cell proliferation and protecting against cell death [14]. Here, SLC52A3 is linked to esophageal squamous cell carcinoma.